Bensarazid with L dopa in the treatment of Parkinson's disease

Simple item page
dc.contributor.authorVan Wieringen, A.en_ZA
dc.date.accessioned2011-03-18T14:57:57Z
dc.date.available2011-03-18T14:57:57Z
dc.date.issued1974-02
dc.descriptionCITATION: Van Wieringen, A. 1974. Bensarazid with L-Dopa in the treatment of Parkinson's disease. S Afr Med J, 48(2):206-209.en_ZA
dc.descriptionThe original publication is available at http://www.samj.org.zaen_ZA
dc.description.abstractENGLISH ABSTRACT: A short review is given of the pharmacokinetics and pharmacodynamics of the decarboxylase inhibitor Ro 4-4602. The results obtained in 20 patients using this drug in combination with L dopa, are described. Reduction in the total dosage of L dopa by 1/6 to 1/10 the single preparation gave marked relief of nausea. The induction period of the dosage was smoother, and an optimum dose could be reached sooner with earlier signs of improvement in comparison with the single drug.en_ZA
dc.description.versionPublisher’s version
dc.format.extent4 pagesen_ZA
dc.identifier.citationVan Wieringen, A. 1974. Bensarazid with L-Dopa in the treatment of Parkinson's disease. S Afr Med J, 48(2):206-209.en_ZA
dc.identifier.issn2078-5135 (online)
dc.identifier.issn0256-9574 (print)
dc.identifier.urihttp://hdl.handle.net/10019.1/7761
dc.language.isoen_ZAen_ZA
dc.publisherHealth & Medical Publishing Groupen_ZA
dc.rights.holderSouth African Medical Journalen_ZA
dc.subjectParkinson's diseaseen_ZA
dc.subjectPalsy, Shaking -- Treatmenten_ZA
dc.subjectDihydroxyphenylalanineen_ZA
dc.subjectDopaen_ZA
dc.titleBensarazid with L dopa in the treatment of Parkinson's diseaseen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
vanwieringen_bensarazid_1974.pdf
Size:
2.52 MB
Format:
Adobe Portable Document Format
Description:
Publishers' Version
Download
Collections
Research Articles (General Internal Medicine)